We only have this paper's title and publication details.
Read it at the sourceRandomized controlled trial shows improved response rate in myelodysplastic syndrome patients treated with ATRA plus decitabine, indicating better outcomes.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: